|Articles|May 1, 2003
Consumers, unions charge PBMs with deceiving plans and patients
Author(s)Tracey Walker
Plaintiffs try to develop overcharging harm as an unfair competition claim
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Robyn Crosson, J.D., Navitus Health Solutions
2
Yesafili, an Eylea biosimilar, launches with a price of $1,445
3
Ashley Holzworth-Nash, Pharm.D., Evernorth
4
Genomic testing nearly triples among Medicare patients, but NGS use remains low
5


















